These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3116031)

  • 61. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Fossati P
    Fertil Steril; 1985 Sep; 44(3):356-60. PubMed ID: 3161758
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endocrine effects of ovarian electrocautery in patients with polycystic ovarian disease.
    Gjønnaess H; Norman N
    Br J Obstet Gynaecol; 1987 Aug; 94(8):779-83. PubMed ID: 3117092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.
    Paradisi R; Venturoli S; Pasquali R; Capelli M; Porcu E; Fabbri R; Flamigni C
    J Endocrinol Invest; 1986 Apr; 9(2):139-44. PubMed ID: 3086422
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
    Dunaif A; Graf M
    J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.
    Chang RJ; Mandel FP; Wolfsen AR; Judd HL
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1265-7. PubMed ID: 6281296
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.
    Ditkoff EC; Fruzzetti F; Chang L; Stancyzk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):603-7. PubMed ID: 7852527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
    Werlin LB; Hodgen GD
    J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.
    Genazzani AD; Battaglia C; Gamba O; Petraglia F; Malavasi B; Genazzani AR
    J Assist Reprod Genet; 2000 May; 17(5):269-75. PubMed ID: 10976414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adrenal abnormalities in polycystic ovary syndrome.
    Loughlin T; Cunningham S; Moore A; Culliton M; Smyth PP; McKenna TJ
    J Clin Endocrinol Metab; 1986 Jan; 62(1):142-7. PubMed ID: 3079598
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
    Couzinet B; Le Strat N; Brailly S; Schaison G
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1031-5. PubMed ID: 2943752
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comprehensive approach to clinical background and effect of bromocriptine administration in patients with endocrinological polycystic ovarian disease].
    Aisaka K; Kaneda S; Tsuzuki H; Tawada T; Kokuho K; Toriya Y; Nojima M; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):101-12. PubMed ID: 2332079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
    Dunaif A
    J Clin Endocrinol Metab; 1986 Jul; 63(1):215-21. PubMed ID: 3086357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1716-22. PubMed ID: 7989480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Successful treatment of endometriosis in women with continuous subcutaneous infusion of gonadotropin-releasing hormone agonist (GnRH-A)].
    Masaoka K; Kitazawa M; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):405-11. PubMed ID: 2501437
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Responses of serum gonadotrophins to LH-releasing hormone and oestrogens in Japanese women with polycystic ovaries.
    Aono T; Miyazaki M; Miyake A; Kinugasa T; Kurachi K; Matsumoto K
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):840-9. PubMed ID: 196471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome.
    McCartney CR; Bellows AB; Gingrich MB; Hu Y; Evans WS; Marshall JC; Veldhuis JD
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E902-8. PubMed ID: 14736706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?
    Levin JH; Carmina E; Lobo RA
    Fertil Steril; 1991 Oct; 56(4):635-40. PubMed ID: 1915936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.